Corcept Therapeutics reported $50.24M in Cash and Equivalent for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US USD 436.58M 296.75M
Ani Pharmaceuticals ANIP:US USD 56.28M 7.1M
Ardelyx ARDX:US USD 61.63M 11.2M
Aurora Cannabis Inc ACB:CN CAD 369.28M 68.53M
Biomarin Pharmaceutical BMRN:US USD 761.52M 141.71M
Bristol Myers Squibb BMY:US USD 7.73B 3.02B
Canopy Growth Corp WEED:CN CAD 318.43M 6.29M
Corcept Therapeutics CORT:US USD 50.24M 14.9M
Depomed DEPO:US USD 64.83M 12.56M
Eli Lilly And LLY:US USD 2.62B 5.5M
Esperion Therapeutics ESPR:US USD 159.4M 36.46M
Knight Therapeutics Inc GUD:CN CAD 4.27M 5.53M
Lannett LCI:US USD 77.92M 9.94M
Lexicon Pharmaceuticals LXRX:US USD 18.83M 2.62M
Nektar Therapeutics NKTR:US USD 105.76M 28.21M
Novartis NOVN:VX USD 8.73B 5.1B
Novartis NVS:US USD 8.73B 5.1B
Omeros OMER:US USD 145.53M 131.4M
Pacira Pharmaceuticals PCRX:US USD 109.42M 12.64M
Supernus Pharmaceuticals SUPN:US USD 111.49M 61.94M
Tg Therapeutics TGTX:US USD 109.86M 37.21M
Ziopharm Oncology ZIOP:US USD 37.81M 22.2M